Literature DB >> 3951078

Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus.

P Farci, J L Gerin, M Aragona, I Lindsey, O Crivelli, A Balestrieri, A Smedile, H C Thomas, M Rizzetto.   

Abstract

The IgM class antibody to the hepatitis delta virus (HDV) was determined in different clinical categories of hepatitis B surface antigen carriers infected by the HDV (positive in the test for total antibody to HDV). The IgM antibody was found at high titers in each of 70 patients with inflammatory liver disease and at a low titer in one of six patients with inactive cirrhosis; it was not found in eight carriers with normal liver histology. The IgM antibody persisted in high titer over many years in patients with unremitting or progressive liver disease, but declined or disappeared before the homologous IgG antibody in the patients whose disease improved or resolved. Testing for IgM antibody to HDV distinguishes hepatitis B surface antigen carriers who have underlying inflammatory HDV liver disease from those with past HDV infection and provides prognostic information on the course of chronic HDV hepatitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3951078

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  9 in total

Review 1.  Immunopathogenesis of viral hepatitis.

Authors:  M U Mondelli
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Serological responses to HBV infection.

Authors:  E A Fagan; R Williams
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

Review 3.  Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.

Authors:  Nicole D Ferrante; Vincent Lo Re
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

4.  Evaluation of commercial enzyme immunoassays for detection of hepatitis delta antigen and anti-hepatitis delta virus (HDV) and immunoglobulin M anti-HDV antibodies.

Authors:  A G Shattock; M C Morris
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

Review 5.  Immunodiagnosis of viral hepatitides A to E and non-A to -E.

Authors:  G Yang; G N Vyas
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

Review 6.  Delta hepatitis: molecular biology and clinical and epidemiological features.

Authors:  L B Polish; M Gallagher; H A Fields; S C Hadler
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

7.  The aetiology of acute hepatitis in Taiwan: acute hepatitis superimposed on HBsAg carrier state as the main aetiology of acute hepatitis in areas with high HBsAg carrier rate.

Authors:  C M Chu; I S Sheen; Y F Liaw
Journal:  Infection       Date:  1988 Jul-Aug       Impact factor: 3.553

Review 8.  Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virus.

Authors:  Carla Usai; Upkar S Gill; Anna C Riddell; Tarik Asselah; Patrick T Kennedy
Journal:  Aliment Pharmacol Ther       Date:  2022-03-16       Impact factor: 9.524

9.  Anti-HDV IgM as a marker of disease activity in hepatitis delta.

Authors:  Anika Wranke; Benjamin Heidrich; Stefanie Ernst; Beatriz Calle Serrano; Florin Alexandru Caruntu; Manuela Gabriela Curescu; Kendal Yalcin; Selim Gürel; Stefan Zeuzem; Andreas Erhardt; Stefan Lüth; George V Papatheodoridis; Birgit Bremer; Judith Stift; Jan Grabowski; Janina Kirschner; Kerstin Port; Markus Cornberg; Christine S Falk; Hans-Peter Dienes; Svenja Hardtke; Michael P Manns; Cihan Yurdaydin; Heiner Wedemeyer
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.